Study Management & Closure: Dissemination of findings
You should disseminate your research findings in a timely and appropriate fashion (e.g. peer reviewed publication or presenting at scientific meetings). If you believe that your research findings may be best exploited by the commercial sector, Universities, the NHS and funders have technology transfer offices that can help with ensuring inventions are adequately protected before public disclosure (see ‘Consult others - Research and Development office' on this Tool Kit).
The person with overall responsibility for the programme of research should authorise publication of results. Research findings with substantial implications for clinical practice or which are likely to attract strong public interest should be drawn to the attention of the research funder before publication.
Participants: You should also consider how best to feed back your research findings to study participants, and other interested groups.
Adverse outcomes: You should consider if it is necessary to inform the wider research community of specific unexpected adverse outcomes which you have encountered during your research, and decide how best to do this. Such events occurring during a clinical trial of an investigational medicinal product (CTIMP) must be reported to the Medicines and Healthcare products Regulatory Agency (MHRA). Systems are available to report adverse outcomes related to: drugs (prescription and over the counter), herbal remedies, devices and blood products (see resources below).
An initiative that seeks to improve the quality of scientific publications by promoting transparent and accurate reporting of health research. Access to ORION (Outbreak Reports and Intervention studies Of Nosocomial infection), STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) and other publication guidelines.Good Practice for some em studies (not applicable for all) Date added: 23 October 2008
Consolidated Standards of Reporting Trials Group website provides access to the CONSORT statement which defines the minimum set of requirements for reporting randomised controlled trials and other reporting toolsGood Practice for some em studies (not applicable for all) Date added: 23 October 2008
This document sets out the principles that MRC-funded scientists must take into account when planning and conducting research, and when recording, reporting, and applying the resultsGood Practice for all research Date added: 23 October 2008